Overview

Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET

Status:
Recruiting

Trial end date:
2020-04-20

Target enrollment:

Participant gender:

Summary

The object of this study is to evaluate the efficacy of extended letrozole co-treatment with GnRH-antagonist protocol in ovarian stimulation of poor responder patients undergoing IVF-ET.

Phase:

Phase 2

Details

Lead Sponsor:

Cairo University

Treatments:

Cetrorelix
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Hormone Antagonists
Hormones
Letrozole
LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-
Polyestradiol phosphate
Prolactin Release-Inhibiting Factors